IBM: Big Blue Is Not Going Back To The Dinosaur Age

Equity Lab 103 Followers Follow Summary IBM faced Q2 revenue pressure from mainframe weakness, but underlying software growth and cash generation remain robust. Hybrid Cloud and Data segments delivered double-digit growth, positioning IBM for evolving enterprise IT and AI-driven demand. Management expects 2026 free cash flow to rise by ~$1bn, supporting a Buy rating despite trimmed revenue guidance. My DCF assigns a fair value of $241/share, with sensitivity analysis indicating attractive risk/reward under conservative assumptions. Getty Images IBM ( IBM ) had a rough Q2. Growth slowed , management cut its revenue outlook, and the shares took a beating. At first glance, this seems to challenge my previous thesis . But once we look under the hood, I think This article was written by Equity Lab 103 Followers Follow I am an equity investor with a strong focus on fundamental, bottom-up stock analysis combined with a structured macro framework. My investment approach centers on understanding business models in depth, assessing competitive positioning, and evaluating long-term value creation through disciplined valuation work. I focus on identifying companies with resilient cash flows, strong capital allocation, and durable competitive advantages. My sector focus is primarily on technology, healthcare, and utilities. I am particularly interested in how company fundamentals interact with broader macroeconomic developments. Alongside bottom-up research, I monitor key macro indicators such as interest rates, inflation, credit conditions, and policy developments to assess their impact on sector dynamics and valuation multiples I have gained experience in stock picking and portfolio management within institutional investment environments, contributing to idea generation and portfolio construction. I write on Seeking Alpha to publish data-driven investment theses grounded in fundamental analysis and valuation discipline. My objective is to provide clear, independent analysis with a long-term investment perspective. Analyst’s Disclosure: I/we have a beneficial long position in the shares of IBM either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.